Illumina stock forecast.

Genomic sequencing leader Illumina ( ILMN -8.05%) recently provided guidance for 2022 and revealed some of its plans for the year. In this Motley Fool Live video, recorded on Jan. 12, Fool ...

Illumina stock forecast. Things To Know About Illumina stock forecast.

Illumina Stock Forecast Over the next 52 weeks, Illumina has on average historically risen by 25.1% based on the past 23 years of stock performance. Illumina has risen higher in 14 of those 23 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.87%Find the latest Bionano Genomics, Inc. (BNGO) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...Looking at Illumina's most recent earnings report, Q2 2023 revenue stands at $1.176B, a slight increase from Q2 2022's $1.162B. Gross margin dropped to 62.2% from 66.0%. R&D expenses rose to $358M ...Oct 16, 2023 · In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ... Illumina stock gained 1.7% premarket on Friday and has dropped 18.3% in the ... Revenue in the latest quarter was $2 billion higher than the $20.9 billion consensus forecast among analysts on Wall ...

Genomic sequencing leader Illumina ( ILMN -8.05%) recently provided guidance for 2022 and revealed some of its plans for the year. In this Motley Fool Live video, recorded on Jan. 12, Fool ...Illumina generated revenue of $2.75 billion last year, and the company is on track to make around $3.3 billion in 2018. Within the next 10 years, Illumina's market should be much bigger. It doesn ...Discover historical prices for ILMN stock on Yahoo Finance. View daily, weekly or monthly format back to when Illumina, Inc. stock was issued.

Illumina, Inc. (NASDAQ:ILMN) Q1 2023 Earnings Call Transcript April 25, 2023 Illumina, Inc. beats earnings expectations. Reported EPS is $0.08, expectations were $0.03. Operator: Good day, ladies ...

Price Target. $194.56. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media Sustainability. Current. Insider Ownership. Percentage.Best genomics stocks of 2023. Data source: The Motley Fool. Data current as of June 14, 2023. Genomics Company. Market Capitalization. Description. Illumina ( NASDAQ:ILMN ) $32.4 billion. Industry ...Illumina stock forecast. Ten analysts forecast the average price in 12 months at $346.00 with a high forecast of $400.00 and a low forecast of $280.00. The average price target represents a 28.09% ...Find the latest C3.ai, Inc. (AI) stock quote, history, news and other vital information to help you with your stock trading and investing.

Illumina stock forecast. Ten analysts forecast the average price in 12 months at $346.00 with a high forecast of $400.00 and a low forecast of $280.00. The average price target represents a 28.09% ...

Illumina. Market Cap. Today's Change. (-0.92%) -$0.88. Current Price. $94.32. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services ...

Find the latest Illumina, Inc. (ILMN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance17 Agu 2023 ... Illumina's second-quarter results touch off a 9% drop in the stock price, as well as 12-month price-target cuts by eight analysts.Within the last quarter, Illumina (NASDAQ:ILMN) has observed the following analyst ratings: According to 11 analyst offering 12-month price targets in the last 3 months, Illumina has an average ...https://www.illumina.com. Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells ...The Federal Trade Commission on Monday ordered Illumina to divest its controversial acquisition of cancer test developer Grail, saying the deal would stifle competition and innovation. The ...

June 14, 2023 at 11:22 AM · 5 min read. Illumina, Inc. ILMN is well poised for growth in the coming quarters, owing to solid long-term growth potential in the oncology space. The company ended ...Earnings tumbled 81% and lagged forecasts for 26 cents. Sales fell 7% in constant currency. Analysts called for $1.07 billion in sales. ... Illumina Stock Tumbles As Sales, Profits Decline — Why ...Illumina Reports Financial Results for Second Quarter of Fiscal Year 2022. August 11, 2022. Revenue of $1.16 billion for Q2 2022, up 3% from Q2 2021, and up 5% on a constant currency basis. GAAP diluted loss per share of $ (3.40) for Q2 2022, compared to GAAP diluted earnings per share of $1.26 for Q2 2021; GAAP diluted loss per share for …THE LAWSUIT: A class action securities lawsuit was filed against Illumina, Inc. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between May 1, 2023 and October 16, 2023. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) …Based on short-term price targets offered by 16 analysts, the average price target for Illumina comes to $199.44. The forecasts range from a low of $100.00 to a high of $334.00. The average price ...Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response to Carl Icahn's public statements and letters to Illumina's ...Who We Are. GRAIL is a healthcare company innovating to solve medicine’s most important challenges. Our team of leading scientists, engineers and clinicians are on an urgent mission to detect cancer early, …

Illumina (ILMN 0.51%) stock has been a huge winner, running up 2,400% over its 21-year history. Will the stock continue to double again, and again, and again?On the stock market today, Illumina stock toppled 7.9% to 470.36. ... Illumina Recovers After Torching Its 2023 Outlook; Announces A 'Huge Accomplishment' S&P 500: Carnival, Tesla Headline Big-Cap ...

Nov 29, 2023 · The stock price has decreased by -51.30% in the last 52 weeks. The beta is 1.16, so Illumina's price volatility has been higher than the market average. Beta (1Y) ILMN. Illumina, Inc. 98.34. +0.58. +0.59%. Activist-investor Carl Icahn sued the board of directors at genetic testing company Illumina and accused them of breaching their fiduciary duties ...Dec 3, 2023 · https://www.illumina.com. Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells ... July 10, 2023 — 12:15 am EDT. Illumina stock (NASDAQ: ILMN) currently trades at $187 per share, roughly 51% below its level in March 2021, and it can see solid returns over time. ILMN saw its ...Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.Illumina, Inc. Common Stock (ILMN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. New York, United States , Dec. 04, 2023 (GLOBE NEWSWIRE) -- The Global Blood Group Typing Market Size is to Grow from USD 1.78 Billion in 2022 to USD 3.98 Billion by 2032, at a Compound Annual ...Diving deeper into the forecasts for Illumina mentioned earlier will help you understand how analysts view the stock going forward. Luckily, you can check out what analysts are forecasting by clicking here. If you are no longer interested in Illumina, you can use our free platform to see our list of over 50 other stocks with a high growth ...Get the latest Illumina, Inc. (ILMN) stock news and headlines to help you in your trading and investing decisions.

Oct 16, 2023 · In the last 3 months, 14 analysts have offered 12-month price targets for Illumina. The company has an average price target of $203.64 with a high of $285.00 and a low of $100.00. Below is a ...

Nov 4, 2018 · Illumina generated revenue of $2.75 billion last year, and the company is on track to make around $3.3 billion in 2018. Within the next 10 years, Illumina's market should be much bigger. It doesn ...

Illumina Share Price Live Today:Get the Live stock price of ILMN Inc., and quote, performance, latest news to help you with stock trading and investing.Nov 29, 2023 · The Illumina stock prediction results are shown below and presented as a graph, table and text information. Illumina stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Illumina analysts is $ 131.5. Today 200 Day Moving Average is the resistance level (178.12 $). Penny stocks may sound like an interesting investment option, but there are some things that you should consider before deciding whether this is the right investment choice for you.Mar 20, 2023 · Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today issued the following response to Carl Icahn's public statements and letters to Illumina's ... The average price target for Illumina is $135.00. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $260.00 ,the lowest forecast is $50.00. The average price target represents 32.91% Increase from the current price of $101.57. Find real-time MRNA - Moderna Inc stock quotes, company profile, news and forecasts from CNN Business.Illumina’s stock on track for lowest close in 10 years after cutting guidance Nov. 10, 2023 at 10:16 a.m. ET by Ciara Linnane Biotech and Pharma Illumina Stock Is the Worst Performer in the S&P 500. Following the FTC Chief Administrative Law Judge's (ALJ) decision in favor of Illumina in September 2022, Illumina believes that it has a strong case on appeal. Illumina will move as quickly as possible and seeks to arrive at a resolution in the US Court of Appeals by late 2023 or early 2024, at approximately the same time as the decision in ...Illumina. Market Cap. Today's Change. (-0.92%) -$0.88. Current Price. $94.32. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services ...Dec 3, 2023 · https://www.illumina.com. Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells ... Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic ...View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

11 Sep 2023 ... Illumina's position is exceptionally strong. This is due to the flywheel of leading position, revenues, very high gross margin, and R&D spending ...People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.Detailed Financial Results for Illumina. Our earnings reports, supplementary data, 10Q and 10K, and selected other documents are available below by quarter. Please reach out to our Investor Relations team at [email protected] if you have questions.Information about Illumina's executive officers and directors, including information regarding the direct or indirect interests, by security holdings or otherwise, is available in Illumina's preliminary proxy statement for its 2023 Annual Meeting, which was filed with the SEC on March 30, 2023, and will be included in Illumina's definitive ...Instagram:https://instagram. best moving averages for swing tradingold chinese coins valuertx corp1000 car payment The average Illumina stock price prediction forecasts a potential upside of 58.12% from the current ILMN share price of $109.79. What is ILMN's forecast return on equity (ROE) for 2023-2025? ( NASDAQ : ILMN ) forecast ROE is N/A , which is considered weak . Illumina Inc Stock Forecast and Price Target. According to fourteen experts, who recently provided their 2023 price targets for Illumina Inc, the average price target is $140.00, with a high estimate of $260.00 and a low estimate of $50.00. That is a potential upside of approximately 37.32% from the last closing price of $101.95 on November, 2023. news on canopy growth corporationpcef stock Shares of Illumina ( ILMN 1.47%) were tumbling 10.1% lower this week as of the market close on Thursday, according to data from S&P Global Intelligence. Most of the decline came after a European ... air conditioning etf Real time Illumina (ILMN) stock price quote, stock graph, news & analysis. Shares of ILMN opened at $109.79 on Monday. Illumina, Inc. has a 1-year low of $89.00 and a 1-year high of $238.55. The stock has a market cap of $17.43 billion, a PE ratio of -15.42, a P/E/G ...